Serum elafin as a potential inflammatory marker in psoriasis

Area of Science:

• Dermatology
• Biochemistry
• Immunology

Background:

• Psoriasis is a chronic skin condition with complex, not fully understood, pathogenesis.
• Understanding the molecular mechanisms of psoriasis is crucial for developing effective treatments.

Purpose of the Study:

• To quantify serum elafin levels in psoriasis patients and healthy controls.
• To investigate the correlation between elafin levels and psoriasis severity, using the Psoriasis Area and Severity Index (PASI).
• To assess the relationship between elafin and established inflammation markers like C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR).

Main Methods:

• A case-control study involving 26 psoriasis patients and 26 healthy controls.
• Serum elafin levels were determined using Enzyme-Linked Immunosorbent Assay (ELISA).
• Psoriasis severity was assessed via PASI scores; CRP and ESR levels were also measured.

Main Results:

• A highly significant difference in serum elafin levels was observed between psoriasis cases and controls (P < 0.001).
• Serum elafin levels showed a significant positive correlation with psoriasis severity (PASI scores).
• Elafin levels also correlated significantly with inflammation markers CRP and ESR.

Conclusions:

• Serum elafin levels are significantly elevated in individuals with psoriasis.
• Elafin serves as a potential biomarker reflecting both the severity of psoriasis and the systemic inflammatory state.